Ethnic differences in efficacy of drug treatment in patients with an acute manic episode: an individual patient data meta-analysis of randomized placebo-controlled trials.

IF 2.8 2区 医学 Q2 PSYCHIATRY
Bram W C Storosum, Sem E Cohen, Cedrine A Steinz, Taina K Mattila, Carlijn C Welten, Wim van den Brink, Kit Roes, Lieuwe de Haan, Damiaan A J P Denys, Jasper B Zantvoord
{"title":"Ethnic differences in efficacy of drug treatment in patients with an acute manic episode: an individual patient data meta-analysis of randomized placebo-controlled trials.","authors":"Bram W C Storosum, Sem E Cohen, Cedrine A Steinz, Taina K Mattila, Carlijn C Welten, Wim van den Brink, Kit Roes, Lieuwe de Haan, Damiaan A J P Denys, Jasper B Zantvoord","doi":"10.1186/s40345-025-00371-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Little is known about the effect of ethnicity on drug treatment in patients with an acute manic episode. The aim of this study is to determine whether ethnicity moderates the response to drug treatment in patients with an acute manic episode, and whether this moderation is independent of potential confounders.</p><p><strong>Methods: </strong>We analysed ten short-term placebo-controlled registration trials of atypical antipsychotics and anticonvulsive mood stabilizers in patients with an acute manic episode (n = 2199). A one-step random effects individual patient data meta-analysis (IPD) was applied to establish the moderating effect of ethnicity on symptom improvement on the Young Mania Rating Scale (Y)MRS and on response defined as 50% (Y)MRS symptom reduction. These analyses were corrected for baseline severity, age, and gender. A two-step IPD comparing these outcomes between White, Black and Asian patients. Additionally, a conventional meta-analysis was performed to determine the effect size of drug treatment separately for these ethnic groups.</p><p><strong>Results: </strong>In the complete dataset, 60.4% of the patients was White, 8.0% was Black, 12.7% was Asian, 33.7% was of other ethnicities. Ethnicity did not significantly moderate the efficacy of drug treatment: pooled beta-coefficient (β) for the interaction between treatment and the ethnicities White, Black and Asian, varying from 0.889 to 0.899 with overlapping confidence-intervals ranging from 2.356 to 2.430 in the main analysis. The drug treatment effects were significant in all three analysable ethnicity groups compared to placebo.</p><p><strong>Discussion: </strong>In White,Black, and Asian patients with an acute manic episode drug treatment is equally effective.</p>","PeriodicalId":13944,"journal":{"name":"International Journal of Bipolar Disorders","volume":"13 1","pages":"8"},"PeriodicalIF":2.8000,"publicationDate":"2025-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11847768/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Bipolar Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40345-025-00371-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Little is known about the effect of ethnicity on drug treatment in patients with an acute manic episode. The aim of this study is to determine whether ethnicity moderates the response to drug treatment in patients with an acute manic episode, and whether this moderation is independent of potential confounders.

Methods: We analysed ten short-term placebo-controlled registration trials of atypical antipsychotics and anticonvulsive mood stabilizers in patients with an acute manic episode (n = 2199). A one-step random effects individual patient data meta-analysis (IPD) was applied to establish the moderating effect of ethnicity on symptom improvement on the Young Mania Rating Scale (Y)MRS and on response defined as 50% (Y)MRS symptom reduction. These analyses were corrected for baseline severity, age, and gender. A two-step IPD comparing these outcomes between White, Black and Asian patients. Additionally, a conventional meta-analysis was performed to determine the effect size of drug treatment separately for these ethnic groups.

Results: In the complete dataset, 60.4% of the patients was White, 8.0% was Black, 12.7% was Asian, 33.7% was of other ethnicities. Ethnicity did not significantly moderate the efficacy of drug treatment: pooled beta-coefficient (β) for the interaction between treatment and the ethnicities White, Black and Asian, varying from 0.889 to 0.899 with overlapping confidence-intervals ranging from 2.356 to 2.430 in the main analysis. The drug treatment effects were significant in all three analysable ethnicity groups compared to placebo.

Discussion: In White,Black, and Asian patients with an acute manic episode drug treatment is equally effective.

急性躁狂发作患者药物治疗疗效的种族差异:随机安慰剂对照试验的个体患者数据荟萃分析。
背景:种族对急性躁狂发作患者药物治疗的影响知之甚少。本研究的目的是确定种族是否会调节急性躁狂发作患者对药物治疗的反应,以及这种调节是否独立于潜在的混杂因素。方法:我们分析了10项非典型抗精神病药物和抗惊厥情绪稳定剂在急性躁狂发作患者中的短期安慰剂对照注册试验(n = 2199)。采用一步随机效应个体患者数据荟萃分析(IPD)来确定种族对青年躁狂症评定量表(Y)MRS症状改善和定义为50% (Y)MRS症状减轻的反应的调节作用。这些分析根据基线严重程度、年龄和性别进行了校正。两步IPD比较白人,黑人和亚洲患者的这些结果。此外,进行了传统的荟萃分析,以确定药物治疗对这些种族群体的效果大小。结果:在完整数据集中,60.4%的患者为白人,8.0%为黑人,12.7%为亚洲人,33.7%为其他种族。种族对药物治疗的疗效没有显著影响:治疗与白人、黑人和亚洲人种族之间相互作用的汇总β系数(β)在主分析中从0.889到0.899不等,重叠置信区间从2.356到2.430。与安慰剂相比,药物治疗效果在所有三个可分析的种族组中都是显著的。讨论:对于白人、黑人和亚洲人的急性躁狂发作,药物治疗同样有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Bipolar Disorders
International Journal of Bipolar Disorders Medicine-Psychiatry and Mental Health
CiteScore
6.70
自引率
5.00%
发文量
26
审稿时长
13 weeks
期刊介绍: The International Journal of Bipolar Disorders is a peer-reviewed, open access online journal published under the SpringerOpen brand. It publishes contributions from the broad range of clinical, psychological and biological research in bipolar disorders. It is the official journal of the ECNP-ENBREC (European Network of Bipolar Research Expert Centres ) Bipolar Disorders Network, the International Group for the study of Lithium Treated Patients (IGSLi) and the Deutsche Gesellschaft für Bipolare Störungen (DGBS) and invites clinicians and researchers from around the globe to submit original research papers, short research communications, reviews, guidelines, case reports and letters to the editor that help to enhance understanding of bipolar disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信